Evidence map›Paper›PMID 30139952›Full record

SynthesisGenes and immunity2019

Association between thyroglobulin polymorphisms and autoimmune thyroid disease: a systematic review and meta-analysis of case-control studies.

Ming-Liang Zhang, Dong-Ming Zhang, Cai-E Wang, Xiao-Long Chen, Fang-Zhou Liu, Jian-Xue Yang

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Genes and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ming-Liang ZhangDepartment of Pharmacy, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang; The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
Dong-Ming ZhangDepartment of Endocrinology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Cai-E WangDepartment of Pharmacy, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang; The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
Xiao-Long ChenDepartment of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Fang-Zhou LiuHenan Province Chinese Medicine Research Institute, Zhengzhou, Henan, China.
Jian-Xue YangDepartment of Neurology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China. docyjx1969@126.com.
First Affiliated Hospital of Henan University of Science and Technology · CNFirst Affiliated Hospital of Henan University of Traditional Chinese Medicine · CNFirst Affiliated Hospital of Zhengzhou University · CNSecond Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging evidence revealed that thyroglobulin (TG) contributes to the development of autoimmune disease, and the relationship between TG and autoimmune thyroid disease (AITD) is still controversial. The aim of this study was to quantify the association between rs2076740, rs853326, rs180223, and rs2069550 TG polymorphisms and risk of AITD using a meta-analysis approach. We identified all studies that assessed the association between TG polymorphisms and AITD from PubMed, Embase, and Web of Science databases. A total of 3013 cases and 1812 controls from ten case-control studies were included. There was no significant associations found between rs2069550, rs180223, and rs853326 polymorphisms and AITD risk. The association between the rs2076740 polymorphism and AITD risk was significant in the codominant model (P = 0.005), suggesting the CC rs2076740 genotype might be a protective factor for AITD. Sensitivity analysis by removing one or two study changed the results in dominant rs2076740 and rs853326 and rs2069550 allele models (P = 0.016, 0.024, 0.027). Latitude and ethnicity significantly affected the association between rs2076740 and rs2069550 polymorphisms and AITD, indicating their protective effects in allele or dominant model (P = 0.012, 0.012, 0.012, 0.009, 0.009). The association between rs2076740, rs2069550, and rs853326 polymorphisms and AITD risk is significantly affected by study characteristics.

Indexed as

Polymorphism, Single NucleotideAllelesCase-Control StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleRisk FactorsThyroglobulinThyroiditis, AutoimmuneThyroglobulin

Identifiers

PMID30139952
OpenAlexW2888174661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.